PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsCastration-resistant prostatic neoplasms
MeSH D064129 - castration-resistant prostatic neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D011471:Prostatic neoplasms
113 Companies
52 Drugs
$
Success rate
D064129: 
Castration-resistant prostatic neoplasms
19 Companies
5 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAbiraterone Abiraterone  2018-10-31   
Glenmark PharmaceuticalsAbiraterone Abiraterone  2019-10-16   
MylanAbiraterone Abiraterone  2018-10-31   
Abiraterone Abiraterone Mylan  2021-08-20   
Johnson & JohnsonAbiraterone Zytiga  2011-04-28 $575 M Q2/24-Q1/25 
Niraparib, Abiraterone Akeega 2027-08-12 2023-08-11   
NovartisVipivotide tetraxetan lutetium lu-177 Pluvicto  2022-12-09   
BayerDarolutamide Nubeqa  2020-03-27   
Dr Reddys LaboratoriesAbiraterone Abiraterone  2020-05-18   
Rising PharmaceuticalsAbiraterone Abiraterone  2019-02-25   
Sun Pharmaceutical IndustriesAbiraterone Yonsa 2034-03-17 2018-05-22   
ApotexAbiraterone Abiraterone  2018-10-31   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
52%
68/132
Phase 2
27%
31/116
Phase 3
32%
12/37
Approved: 3Overall Success rate: 4%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Aglatimagene besadenovec,
Custirsen,
Docetaxol,
Taxane
Johnson & Johnson
Niraparib,
Abiraterone,
Cetrelimab,
Gilvetmab,
Aglatimagene besadenovec,
Glutamic acid,
ONAMETOSTAT,
D-glutamate,
Globulin, immune,
Br9004,
Bos taurus adrenal cortex corticosteroids,
Xenograft,
Solumedrol,
Docetaxol,
Ra223,
Taxane,
Trc-253
Novartis
Vipivotide tetraxetan lutetium lu-177,
Benzocaine,
Fluorodopa f-18,
Dactolisib,
Gilvetmab,
Aglatimagene besadenovec,
Spartalizumab,
Buparlisib,
Doconexent,
Lysine,
Bevifimod,
IERAMILIMAB,
Lotamilast,
Remetinostat,
TEFINOSTAT,
Usistapide,
Fludeoxyglucose f-18,
Globulin, immune,
Ga68,
Aaa617,
Lfa102,
AAA517,
Histone-arginine methyltransferase carm1,
Surlorian,
Docetaxol,
Taxane,
Isoxaflutole
Bayer
Darolutamide,
Rucaparib,
Rucaparib camsylate,
Gilvetmab,
Enoblituzumab,
Aglatimagene besadenovec,
Aspartame,
Bevifimod,
Nepidermin,
Luprolide,
Sustanon,
Histone-arginine methyltransferase carm1,
Bay3546828,
Docetaxol,
Ra223,
Taxane,
Isoxaflutole
Sun Pharmaceutical Industries
Abiraterone,
Aglatimagene besadenovec,
Globulin, immune
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use